Canada markets closed

Valeo Pharma Inc. (VPH.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.8800-0.0300 (-3.30%)
At close: 3:36PM EDT
Currency in CAD

Valuation Measures

Market Cap (intraday) 570.12M
Enterprise Value 371.38M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)4.71
Price/Book (mrq)7.14
Enterprise Value/Revenue 35.76
Enterprise Value/EBITDA 7-11.58

Trading Information

Stock Price History

Beta (5Y Monthly) 3.00
52-Week Change 3-8.33%
S&P500 52-Week Change 333.64%
52 Week High 31.5300
52 Week Low 30.5700
50-Day Moving Average 30.7970
200-Day Moving Average 30.9042

Share Statistics

Avg Vol (3 month) 3109.15k
Avg Vol (10 day) 363.98k
Shares Outstanding 578.79M
Implied Shares Outstanding 6N/A
Float 835.24M
% Held by Insiders 145.15%
% Held by Institutions 10.00%
Shares Short (Sep. 14, 2021) 429.94k
Short Ratio (Sep. 14, 2021) 40.61
Short % of Float (Sep. 14, 2021) 4N/A
Short % of Shares Outstanding (Sep. 14, 2021) 40.04%
Shares Short (prior month Aug. 12, 2021) 422.85k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Oct. 30, 2020
Most Recent Quarter (mrq)Jul. 30, 2021


Profit Margin -71.03%
Operating Margin (ttm)-38.34%

Management Effectiveness

Return on Assets (ttm)-17.82%
Return on Equity (ttm)-228.42%

Income Statement

Revenue (ttm)12.39M
Revenue Per Share (ttm)0.19
Quarterly Revenue Growth (yoy)280.30%
Gross Profit (ttm)1.38M
Net Income Avi to Common (ttm)-8.8M
Diluted EPS (ttm)-0.1340
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.99M
Total Cash Per Share (mrq)0.11
Total Debt (mrq)10.24M
Total Debt/Equity (mrq)104.23
Current Ratio (mrq)1.34
Book Value Per Share (mrq)0.12

Cash Flow Statement

Operating Cash Flow (ttm)-11.71M
Levered Free Cash Flow (ttm)-10.7M